Stockysis — AI-Powered Stock News & Sentiment Analysis

BTIG Reiterates Buy on Oruka Therapeutics, Maintains $73 Price Target

Benzinga Newsdesk www.benzinga.com Neutral 90.4%

Neg 0% Neu 90.4% Pos 0%

BTIG analyst Julian Harrison reiterates Oruka Therapeutics (NASDAQ:ORKA) with a Buy and maintains $73 price target.

Comments

No comments yet. Be the first!